drugset / Trial / NCT02231281
Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Phase 3
Unknown
65 enrolled
Yongtao Sun, MD, PhD
Beijing YouAn Hospital · collabChina Medical University, China · collabFirst Affiliated Hospital of Guangxi Medical University · collabNational Center for AIDS/STD Control and Prevention, China CDC · collabShandong Province Centers for Disease Control and Prevention · collabTang-Du Hospital · collabZhejiang University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the ability of the early initiation of cART or cART in combination with autologous HIV-1 specific cytotoxic T lymphocyte (CTL) infusion to achieve a post-treatment control among treatment-naïve acute HIV-infected adults.
Timeline
- Start
- 2014-08
- Primary completion
- 2018-08
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lamivudine | Other / unclassified | — | — |
| Subject | Lopinavir | Other / unclassified | — | — |
| Subject | Ritonavir | Other / unclassified | — | — |
| Subject | Tenofovir disoproxil fumarate | Small molecule | — | — |
| Subject | Zidovudine | Small molecule | — | — |
Indications
No indication recorded.